• Dublin, Dec. 02, 2022 (GLOBE NEWSWIRE) -- The "Infectious Disease Diagnostics - Market Insights, Competitive Landscape and, Market Forecast - 2027" report has been added to ResearchAndMarkets.com's offering. (globenewswire.com)
  • The Infectious Disease Diagnostic Market is estimated to register growth at a remarkable CAGR forecast during 2022-2027 owing to surge in prevalence of infectious diseases and growing concern regarding the incidences of pandemic and epidemics. (globenewswire.com)
  • The global infectious disease diagnostics market was valued at USD 38.52 billion in 2021 and is estimated to grow at a CAGR of 3.80% during the forecast period (2022-2027) to reach USD 48.10 billion by 2027. (globenewswire.com)
  • Based on the technology segment of the infectious disease diagnostics market, the immunoassays category is projected to register a significant growth in the revenue of the infectious disease diagnosis market during the forecast period (2022-2027). (globenewswire.com)
  • According to the analysis, the Syphilis Immunoassay Diagnostics market size will be valued at USD 512.45 million in 2021 and the total Syphilis Immunoassay Diagnostics revenue will grow at a CAGR of 3.2% from 2022 to 2029 to reach nearly USD 659.31 million. (startribunemag.com)
  • The global in vitro diagnostic market size was valued at USD 132.95 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of -2.8 % from 2023 to 2030. (grandviewresearch.com)
  • For instance, in March 2022, Ion Torrent Genexus Dx Integrated Sequencer was introduced in the market by Thermo Fisher Scientific for research as well as diagnostic purposes. (grandviewresearch.com)
  • The molecular diagnostics application segment held the highest market share of 40.92% in 2022 owing to the launch of novel products and continuous evolution in technology. (grandviewresearch.com)
  • Global adrenocorticotropic hormone (ACTH) market size was estimated at USD 1.39 billion in 2022. (blueweaveconsulting.com)
  • According to Zion Market Research, the global Over The Counter (OTC) Test market size is projected to reach USD 40 billion by 2030 from its value of USD 20 billion in 2022, at a CAGR of 10% during the forecast period. (einpresswire.com)
  • According to the latest research study, the global Over The Counter (OTC) Test Market size was valued at about USD 20 billion in 2022. (einpresswire.com)
  • NEW YORK , July 28, 2023 /PRNewswire/ - The immunodiagnostics market size is set to grow by USD 22,669.75 million between 2022 and 2027 and register an accelerating CAGR of 12% , according to Technavio's latest market research report estimates. (countyenews.com)
  • COVID Testing Kit Market Size was valued at USD 65.69 billion in 2021 and is projected to grow from USD 70.42 billion in 2022 to USD 122.82 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.20 % during the forecast period (2022 - 2030). (marketresearchfuture.com)
  • The global clinical laboratory service market size was estimated at USD 217.53 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 3.2% from 2023 to 2030. (grandviewresearch.com)
  • The global clinical diagnostic market is projected to grow at a CAGR of 5.8% from 2022 to 2028 to reach USD 98 billion in 2028, driven by the rising prevalence of chronic diseases, a gradual shift towards automated testing systems, and expansion of point-of-care testing. (labmedica.com)
  • EMAILWIRE.COM , April 08, 2022 ) The global lateral flow assay components market is projected to reach USD 420 million by 2027 from USD 339 million in 2022, at a CAGR of 4.3% during the forecast period. (westafricana.com)
  • The size of the global lab on chip market was estimated at USD 5,698 million in 2021 and is projected to increase to USD 14,772 million by 2030, at a CAGR of 11.5% from 2022 to 2030 The basis for most LOC fabrication processes is photolithography. (wikipedia.org)
  • The global non-animal alternatives testing market size grew from $1.78 billion in 2022 to $1.94 billion in 2023 at a compound annual growth rate (CAGR) of 9.2% . (thebusinessresearchcompany.com)
  • The companion animal diagnostics market study presents historical market data in terms of value (2020 and 2021), estimated current data (2022), and forecasts for 2029 - by product, technology, animal type, and end user. (chatsdumonde.net)
  • Based on technology, the immunodiagnostics segment is estimated to account for the largest share of this market in 2022. (chatsdumonde.net)
  • Based on product, the consumables segment is estimated to dominate the companion animal diagnostics market in 2022. (chatsdumonde.net)
  • The Global Self-Sampling Blood Collection and Storage Devices Market was valued at US$ 156.40 Million in 2022 and is anticipated to reach US$ 605.09 Million by the end of 2030 with a CAGR of 18.5% from 2023 to 2030. (cognizancemarketresearch.com)
  • The Point of Care Diagnostic Market was analyzed which was worth USD 35.4 Billion in the year 2021, expecting a CAGR of 7.03% during the forecast period (2022-2030), and the market is projected to be valued at USD 65.25 Billion by 2030. (marketresearchcommunity.com)
  • The Endocrine Testing Market was analyzed which was worth USD 2.55 Million in the year 2022, expecting a CAGR of 8.3% during the forecast period (2023-2030), and the market is projected to be valued at USD 4.83 Million by 2030. (marketresearchcommunity.com)
  • The global integrated pest management (IPM) market size will grow from $117.01 billion in 2022 to $127.83 billion in 2023 at a compound annual growth rate (CAGR) of 9.2% . (thebusinessresearchcompany.com)
  • Cosmetic Surgery Market Size was estimated at USD 69.72 billion in 2022 and is poised to reach at 147.29 billion in 2030 anticipated to expand at a compound annual growth rate approx. (articledistrict.com)
  • Increasing prevalence of disorders related to the adrenal gland and growing geriatric population worldwide are projected to propel the expansion of global adrenocorticotropic hormone market during the forecast period between 2023 and 2029. (blueweaveconsulting.com)
  • The Asia Pacific Veterinary Diagnostics Market would witness market growth of 11.6% CAGR during the forecast period (2023-2030). (giiresearch.com)
  • The Japan market is estimated to witness a CAGR of 10.9% during (2023 - 2030). (giiresearch.com)
  • Additionally, The India market would showcase a CAGR of 12.2% during (2023 - 2030). (giiresearch.com)
  • According to this latest publication from Meticulous Research ® , the medical ceramics market is projected to reach $29.93 billion by 2030, at a CAGR of 6.2% during the forecast period 2023-2030. (meticulousresearch.com)
  • In 2023, the bioinert segment is expected to account for the largest share of the medical ceramics market. (meticulousresearch.com)
  • In 2023, North America is expected to account for the largest share of the medical ceramics market, followed by Europe and Asia-Pacific. (meticulousresearch.com)
  • Furthermore, in 2023, the U.S. is expected to be the largest market in North America. (meticulousresearch.com)
  • The global blood screening market in terms of revenue was estimated to be worth $2.4 billion in 2023 and is poised to reach $3.4 billion by 2028, growing at a CAGR of 7.2% from 2023 to 2028. (marketsandmarkets.com)
  • Based on type, in 2023, the nucleic acid extraction & amplification kits & reagents segment is expected to account for the largest share of the sequencing kits market along with sequencing reagents. (meticulousresearch.com)
  • The Single Patient Hemodialysis Machine Market size is expected to grow at an annual average of CAGR 5% during the forecast period (2023-2029). (openpr.com)
  • The India stout market is projected to exhibit a growth rate (CAGR) of 5.9% during 2023-2028. (openpr.com)
  • The 3D Visualization Software Market research report represents major insights on the current growth dynamics as well as the primary revenue generation elements that are available in the 3D Visualization Software industry along with various other factors over the predicted period 2023-2030. (openpr.com)
  • According to The Worldwide Market Reports, the Latest research report on "Online Teaching Platform Market Size, Revenue, Global Analysis, and Forecast 2023 to 2030" The Online Teaching Platform Market research study is a professional report with premium insights into the size of the business, current patterns, drivers, risks, potential outcomes, and major segments. (openpr.com)
  • The Automatic Enzyme Sign Analyzer Market size is expected to grow at an annual average of CAGR 15% during the forecast period (2023-2029). (openpr.com)
  • The Blood Screening Market size is estimated at USD 2.69 billion in 2023, and is expected to reach USD 4.06 billion by 2028, growing at a CAGR of 8.58% during the forecast period (2023-2028). (mordorintelligence.com)
  • For instance, in March 2023, TruDiagnostic, a health data company, formed a new partnership with NADMED, a Finnish nicotinamide adenine dinucleotide (NAD) diagnostic company, to launch a new NAD+ blood diagnostic test for patients in the United States. (mordorintelligence.com)
  • By region, North America is slated to be the largest regional market with a value share of 33.3% at the end of the forecast period, due to constant clinical efforts to establish advanced diagnostics biologics and new drug discovery in the region. (medgadget.com)
  • In terms of region, the global procalcitonin test kits market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. (transparencymarketresearch.com)
  • North America will hold the largest market share in 2021, accounting for more than one-third of the global syphilis immunoassay diagnostics market, and is expected to maintain its revenue dominance by 2029. (startribunemag.com)
  • Geographically, North America is expected to dominate the global clinical diagnostic market share due to its high geriatric population base, rising awareness of laboratory tests, well-established healthcare infrastructure, and the presence of cost-effective diagnostic kits for diseases such as AIDs, and hepatitis C, etc. (labmedica.com)
  • The global task trainers market is further segmented by geography into four major continents namely, North America, Europe, Asia-Pacific, and Rest of the World (RoW). (meticulousresearch.com)
  • North America dominated the global life science reagents market in 2018, and this trend is expected to continue during the forecast period too. (dailybn.com)
  • However, the increase in the number of local manufacturers creating pricing pressure in the market is likely to hamper the growth of the global life science reagents market in North America during the latter half of the forecast period. (dailybn.com)
  • North America is one of the most important regions for adopting and growing new technologies due to flattering government policies to boost innovation, a vast industrial base, and high purchasing power, mainly in developed countries such as the US and Canada. (theinsightpartners.com)
  • North America currently dominates the market for renal biomarkers, and it is expected to continue its stronghold for a few more years. (futuremarketinsights.com)
  • As per Persistence Market Research's latest revised industry analysis, the global immunoassay interference blocker market was valued at US$ 223 Mn in 2020, and is expected to exhibit a CAGR of 6.7% over the forecast period (2021-2031). (medgadget.com)
  • This is expected to drive the immunoassay interference blocker market over the forecast period of 2021 to 2031. (medgadget.com)
  • Moreover, in 2021, the FDA also prioritized home-based molecular diagnostic tests. (grandviewresearch.com)
  • In March 2021, BATM Advanced Communications Ltd. announced the launch of its molecular diagnostics self-test kit for the detection of COVID-19. (grandviewresearch.com)
  • The nasopharyngeal swab segment dominated the market in 2021. (marketresearchfuture.com)
  • However, there was a decrease in routine testing during the first quarter of 2021 due to the lockdown, but the industry has gradually begun to witness growth owing to increased testing volume for COVID-19. (grandviewresearch.com)
  • The global Infectious Disease In-Vitro Diagnostics Market was valued at around US$ 58.7 Bn in 2021. (persistencemarketresearch.com)
  • The global market for the Infectious Disease In-Vitro Diagnostics Market expanded at a CAGR of 4.4% over the last four years (2017-2021). (persistencemarketresearch.com)
  • In January 2021, Sysmex Corporation (Japan) entered into a partnership with Roche Diagnostics (Switzerland) to maximize its strengths including competitive products and services and extensive sales and service networks. (jaipurherald.in)
  • The In-Vitro Diagnostics/IVD Market is projected to reach USD 113.1 billion by 2026 from USD 98.2 billion in 2021, at a CAGR of 2.9% during the forecast period. (jaipurherald.in)
  • For instance, the Global HIV and AIDS Statistics 2021 fact sheet by the Joint United Nations Programme on HIV/AIDS (UNAIDS) estimated that approximately 38.4 million people were living with HIV worldwide in 2021, with 36.7 million being adults and 1.7 million being children (under the age of 15). (mordorintelligence.com)
  • As a result, the cancer in vitro diagnostics (IVD) market is valued at $5,535 million* ($5.5 billion) in 2021, including the demand for companion assays, according to World Market for Cancer Diagnostics , a new report by leading medical market research publisher Kalorama Information. (kaloramainformation.com)
  • According to the latest report by IMARC Group, titled " Immunoassay Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026 ," offers a comprehensive analysis of the industry, which comprises insights on immunoassay market research report . (postingtree.com)
  • The global gene amplification technologies market size is estimated to register a significant CAGR during the forecast period, 2021-2028. (growthmarketreports.com)
  • The application segment is led by antibody capture assays with a share of 39.8% in 2020, owing to high, precise, and accurate results with least interference obtained via immunoassay interference blockers. (medgadget.com)
  • The global multiplex assays market accounted for $73.2 million in 2018, and is expected to reach $123.1 million by 2026, growing at a CAGR of 6.6% from 2019 to 2026. (articlepedia.xyz)
  • Multiplex immunoassays conjugates assays for several target analytes in a single reaction volume, minimizing workflow and sample volume difficulties. (articlepedia.xyz)
  • Multiplex assays hold enormous potential in the R&D of drugs for the treatment of diseases, such as cancer and cardiovascular diseases that drives the market growth for theses assays. (articlepedia.xyz)
  • In addition, surge in adoption of multiplex assays to reduce operation costs and rise in adoption of personalized medicines are anticipated to boost the market growth. (articlepedia.xyz)
  • On the contrary, the emerging economies of Asia-Pacific and LAMEA regions offer lucrative growth opportunities for the expansion of multiplex assays market, due to improvement in healthcare infrastructure in these regions and increase in demand for better healthcare services from majority of the patient population. (articlepedia.xyz)
  • On the basis of type, the market is divided into nucleic acid-based, protein-based multiplex assays, and others. (articlepedia.xyz)
  • Moreover, the emergence of various PoC tests and assays is expected to create significant growth opportunities. (chatsdumonde.net)
  • Liquid biopsies are blood-based molecular tumor assays, which have been on the market for several years. (kaloramainformation.com)
  • Furthermore, growth in biotechnology and biopharmaceutical industries coupled with the emerging trend of smartphone-based formats and multiplex bead assays are creating a positive outlook for the market. (postingtree.com)
  • OBJECTIVE: For the 2019 ASCCP Risk-Based Management Consensus Guidelines, we conducted a systematic review of diagnostic assays for postcolposcopy and posttreatment management. (cdc.gov)
  • however, quantitative viral-load assays should not be used as a diagnostic tool. (medscape.com)
  • Moreover, increase in usage of procalcitonin test for the optimization of course of antibiotic treatment, newer regulatory guidelines emphasizing on increased usage of procalcitonin tests in the golden hours of treatment, and increased levels of awareness about the rapid procalcitonin tests are likely to contribute to the growth of the market during the forecast period. (transparencymarketresearch.com)
  • The immunoassay test kits segment in projected to dominate the global market during the forecast period. (transparencymarketresearch.com)
  • The diagnostic laboratories segment is projected to dominate the global market during the forecast period. (transparencymarketresearch.com)
  • Large number of diagnostic laboratories across the globe, comparatively large volumes of samples for testing in diagnostic laboratories, and growing number of diagnostic laboratories in emerging economies are estimated to boost the segment growth during the forecast period. (transparencymarketresearch.com)
  • The procalcitonin test kits market in Asia Pacific is projected to grow at the highest CAGR during the forecast period. (transparencymarketresearch.com)
  • Syphilis Immunoassay Diagnostics Market Analysis projects global and domestic revenue growth for key players and analyzes the latest market trends for each sub-segment during the forecast period. (startribunemag.com)
  • Asia Pacific is expected to grow at a CAGR of 2.89% during the forecast period.Growing interest in prevention health care Also, industrial development is expected to boost the growth of the region. (startribunemag.com)
  • The region is expected to retain its dominance growing at the second-fastest CAGR during the forecast period owing to the extensive R&D initiatives being undertaken by major market players for the development of novel reagents. (grandviewresearch.com)
  • The global over the counter (OTC) test market is anticipated to grow rapidly over the forecast timeline owing to an increase in the number of chronic disorders such as diabetes, respiratory diseases, and viral diseases. (einpresswire.com)
  • The market share growth by the reagents and consumables segment is significant during the forecast period. (countyenews.com)
  • hence, such factors are expected to fuel the growth of this segment which in turn will drive the market during the forecast period. (countyenews.com)
  • The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. (countyenews.com)
  • The rising demand for biomarker-based tests drives the global immunodiagnostics market growth during the forecast period. (countyenews.com)
  • Hence, such factors are expected to replace traditional drug therapy with personalized devices, which in turn is expected to drive the immunodiagnostics market growth during the forecast period. (countyenews.com)
  • The increase in demand for personalized medicine is a primary trend in the global immunodiagnostics market during the forecast period. (countyenews.com)
  • The global sepsis diagnostics market was estimated at USD 426 million in 2019 and is expected to grow at 8.4% CAGR during the forecast study period. (openpr.com)
  • Moreover, rapid advancements in data management and sample preparation due to the growing volumes of testing samples are anticipated to boost industry growth during the forecast period. (grandviewresearch.com)
  • However, the adoption of at-home testing is expected to hamper the industry growth in the forecast period. (grandviewresearch.com)
  • The global infectious disease rapid diagnostic testing market size is expected to reach USD 51.01 Billion in 2030 and register a revenue CAGR of 7.0% during the forecast period, according to latest analysis by Emergen Research. (gpworldtech.com)
  • Moreover, rising preference for preventive care is expected to increase need for infectious disease diagnostics over the forecast period. (gpworldtech.com)
  • On the other hand, the availability of conventional substitutes such as alternative diagnostics may restrict the growth of the lateral flow assay components market during the forecast period. (westafricana.com)
  • However, the unfavorable reimbursement scenario is expected to restrain the growth of this market during the forecast period. (jaipurherald.in)
  • Oncology segment is expected to witness the fastest growth in the forecast period. (jaipurherald.in)
  • Transparency Market Research (TMR) has published a new report on the life science reagents market for the forecast period of 2019-2027. (dailybn.com)
  • Asia Pacific is expected to be a highly lucrative market for life science reagents during the forecast period. (dailybn.com)
  • Organic waste treatment system market is anticipated to grow at a considerable CAGR of 9.0% during the forecast period. (openpr.com)
  • The latest research study released by Transparency Market Research on "Automotive Seat Belt Height Adjuster Market Forecast to 2019 - 2027 ″ research provides accurate economic, global, and country-level predictions and analyses. (openpr.com)
  • Moreover, with the resumption of diagnosis services, the studied market is expected to grow over the forecast period. (mordorintelligence.com)
  • Furthermore, the rising prevalence of infectious diseases is anticipated to drive market growth over the forecast period. (mordorintelligence.com)
  • Hence, the growing burden of infectious diseases such as HIV is expected to increase demand for early and effective diagnosis, driving market growth over the forecast period. (mordorintelligence.com)
  • Additionally, growing strategic collaboration among the market players is expected to fuel the availability of advanced diagnostic tests in the market, hence anticipated to augment the market growth over the forecast period. (mordorintelligence.com)
  • Thus, all the factors above are expected to boost the blood screening market over the forecast period. (mordorintelligence.com)
  • Further, during the forecast period, the presence of limited key players in the market is expected to offer significant growth opportunities to the market players to expand their customer base, especially in developing countries. (theinsightpartners.com)
  • Additionally, the increased demand of Endocrine Testing in many sectors also boosts the market growth during the forecast period. (marketresearchcommunity.com)
  • Thus, owing to the aforementioned factors, the studied market is expected to grow significantly during the forecast period. (futuremarketinsights.com)
  • This trend is well established in clinical chemistry and hematology disciplines and is now extending to other areas, including immunoassays and molecular diagnostics. (jaipurherald.in)
  • In terms of end-user, the global procalcitonin test kits market is segmented into hospitals, diagnostic laboratories, physician offices, and others. (transparencymarketresearch.com)
  • The key factors responsible for the high CAGR in Asia Pacific are rapidly growing number of hospitals and diagnostic laboratories, improving healthcare infrastructure, and rapidly growing population with bacterial infection in China and India. (transparencymarketresearch.com)
  • The development of automated IVD systems for laboratories and hospitals to provide efficient, accurate, and error-free diagnoses is expected to fuel the market growth. (grandviewresearch.com)
  • Manufacturers produce specialized diagnostic instruments and equipment used by veterinarians and laboratories. (giiresearch.com)
  • Based on End Use, the market is segmented into Laboratories, Veterinary Hospitals & Clinics, Point-Of-Care/In-House Testing, Research Institutes & Universities. (giiresearch.com)
  • Based on application, the hospital segment is expected to be the most lucrative in the clinical diagnostics market due to the rising patient admission rate, expansion of hospital laboratories worldwide, and huge government efforts to ensure proper availability of modern treatment and diagnostic technologies across hospitals. (labmedica.com)
  • The increased demand for early disease detection, the shift in emphasis from centralized laboratories to decentralized POC testing, and the frequency of infectious diseases around the world all contribute to the market's growth. (persistencemarketresearch.com)
  • In terms of end user, the global life science reagents market has been divided into hospitals & diagnostic laboratories, commercial & contract research manufacturers, academic & research institutes, and others (blood banks, forensic laboratories, and government institutes). (dailybn.com)
  • Diagnostic laboratories provide diagnostic medical testing for infectious agents, toxins, and other disease causes in animal diagnostic samples submitted. (chatsdumonde.net)
  • Increasing Prevalence of chronic diseases along with the Increasing number of hospitals, surgical centers, and diagnostic laboratories, growing need for effective and powerful medication to Boost the Self-sampling blood collection and storage devices Market. (cognizancemarketresearch.com)
  • As they also aid in predicting disease progression and computing drug dosage, renal biomarkers find extensive applications in hospitals and diagnostic laboratories across the globe. (futuremarketinsights.com)
  • It plays a crucial role in clinical diagnostics, pharmaceutical analysis, environmental monitoring, and security and finds application in research centers, hospitals, and laboratories. (postingtree.com)
  • The market is expected to grow at a CAGR of 10% and is anticipated to reach USD 40 billion by 2030. (einpresswire.com)
  • With a projected CAGR of 4.4% for the next ten years, the market is likely to reach a valuation of nearly US$ 93.9 Bn by the end of 2032. (persistencemarketresearch.com)
  • The market size of global non-animal alternatives testing is expected to grow from $2.9 billion in 2027 at a CAGR of 10.5% . (thebusinessresearchcompany.com)
  • According to the report, the global life science reagents market was valued at around US$ 37,000 Mn in 2018, and is projected to expand at a CAGR of nearly 8% from 2019 to 2027. (dailybn.com)
  • The integrated pest management (IPM) market size is expected to grow to $173.51 billion in 2027 at a CAGR of 7.9% . (thebusinessresearchcompany.com)
  • Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Abbott (US), and Thermo Fisher Scientific (US) are the leading players in this market. (jaipurherald.in)
  • Considering consolidation activities in the global market, strategic focus on novel product development and research based on advanced immunoassay interference blockers are some of the key growth strategies by market players. (medgadget.com)
  • The immunoassay test kits, especially the ELISA kits, are widely and most commonly used test kits for the detection of levels of procalcitonin in the blood. (transparencymarketresearch.com)
  • The availability of advanced diagnostic techniques such as immunoassays, radioimmunoassay, and ELISA has increased the demand for ACTH testing. (blueweaveconsulting.com)
  • Computerized immunoassays are a one-step answer for single-particle location without requiring washing steps in view of ELISA utilizing a variety of femtoliter-sized wells. (marketsandmarkets.com)
  • Developments in enzyme-linked immune assay technology (ELISA), polymerase chain reaction (PCR) such as digital PCR, rtPCR, chromatography, single cell technology, next-generation sequencing (NGS), and flow cytometry techniques, and their applications in the healthcare industry such as disease diagnostics and treatment monitoring are propelling the growth of the global life science reagents market. (dailybn.com)
  • thereby, achieving a market value of $1.0 billion by 2030. (giiresearch.com)
  • "Increasing healthcare R&D spending and government support, continual technological advancements, and growing demand for better diagnosis are boosting demand for immunoassay interference blockers," says an analyst of Persistence Market Research. (medgadget.com)
  • blood Bank.Syphilis Immunoassay Diagnostics Market Companies Develop New Technologies to Automate rapid Rejuvenation of plasma (RPR) test using special equipment.they are increasing the lab test Capabilities that take advantage of new software advancements to improve patient outcomes. (startribunemag.com)
  • Technological advancements in terms of portability, accuracy, and cost-effectiveness are projected to be among the major drivers of this market. (grandviewresearch.com)
  • Additionally, advancements in ceramics and emerging economies are expected to provide growth opportunities for the players operating in this market. (meticulousresearch.com)
  • The advancements in ceramics, the rising adoption of dental and orthopedic implants, technological advances in wearable sensors, and the growing focus on microfluidics expenditure contribute to the large market share of the U.S. (meticulousresearch.com)
  • Moreover, government support for large-scale genomic sequencing projects, the increasing applications of genome sequencing in disease diagnostics and precision medicine, emerging economies, and advancements in genomics & proteomics are expected to generate growth opportunities for market stakeholders. (meticulousresearch.com)
  • Moreover, the increase in the incidences of infectious diseases and technical advancements in the life science industry are boosting the growth of the global life science reagents market. (dailybn.com)
  • Technological advancements in the field of life sciences and biotechnology have resulted in numerous changes in healthcare diagnostics, drug discovery, personalized medicines , forensic sciences, and clinical research & development, majorly driving the growth of the life science reagents market. (dailybn.com)
  • We are committed to advancements in the areas of in-vitro diagnostics, medical imaging systems, and patient monitoring and life support. (medicalbuyer.co.in)
  • The report also includes competitor and regional analysis, and contemporary advancements in the global market. (postingtree.com)
  • In addition to this, technological advancements in the field of immunoassays offering expedited results with higher efficacy, detection limits, sensitivity, and cost-efficiency are contributing to the market growth. (postingtree.com)
  • The cosmetic surgery market has experienced significant growth over the past decade, driven by a combination of factors such as increasing disposable income, changing beauty standards, and advancements in medical technology. (articledistrict.com)
  • The growth can be attributed to the increasing adoption of IVD owing to the rise in testing due to the pandemic. (grandviewresearch.com)
  • Due to movement restrictions and lockdowns due to the current COVID-19 pandemic, the growth of the Infectious Disease Rapid Diagnostic Testing industry is expected to be negatively affected. (gpworldtech.com)
  • In addition to the impact of the COVID-19 pandemic on numerous global markets, the Infectious Disease Rapid Diagnostic Testing industry is expected to feel the effect as well. (gpworldtech.com)
  • The report covers the impact analysis of the COVID-19 pandemic on the overall Infectious Disease Rapid Diagnostic Testing industry. (gpworldtech.com)
  • The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. (thebusinessresearchcompany.com)
  • The worldwide impact of the COVID-19 pandemic is expected to bring about positive changes in the market, especially in the field of blood testing. (cognizancemarketresearch.com)
  • These efforts have boosted the global blood collection market in different parts of the world during the pandemic. (cognizancemarketresearch.com)
  • The COVID-19 pandemic has affected the point-of-care diagnostic market both positively and negatively. (marketresearchcommunity.com)
  • The COVID-19 pandemic has had a substantial negative influence on the Endocrine Testing market in many different regions of the world. (marketresearchcommunity.com)
  • As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic. (postingtree.com)
  • The outbreak of COVID-19 pandemic has affected the market as it forced to shut the production units globally. (growthmarketreports.com)
  • The market is further segmented by end user in to healthcare education, hospitals, military, emergency medical services , and voluntary organizations. (meticulousresearch.com)
  • The Electrocardiograph market has been impacted by Covid-19, which includes a significant drop in Electrocardiograph sales due to a lack of visits to healthcare facilities such as hospitals and clinics. (openpr.com)
  • Immunoassays are based on antigen-antibody reactions and therefore they are highly sensitive and specific for the detection of infectious diseases. (globenewswire.com)
  • Substances that modify quantifiable concentration of analytes or change antibody binding can conceivably result in immunoassay interference. (medgadget.com)
  • These substances have the potential to change the concentration of the analytic or alter antibody binding resulting in immunoassay interference. (alliedmarketresearch.com)
  • Each TrueMAB antibody is specifically developed with full-length human proteins produced in HEK293T cells and validated for critical research and diagnostic needs requiring improved antibody sensitivity and specificity. (news-medical.net)
  • First, we argue that antibody-based methods provide a unique opportunity to augment and integrate surveillance across diverse global health initiatives. (cdc.gov)
  • Immunoassay (IA) is a biochemical technique used to measure the concentration or presence of macromolecules analytes in a solution through an antibody or an antigen. (postingtree.com)
  • CDC guidelines recommend testing for HIV infection with a US Food and Drug Administration (FDA)-approved antigen/antibody immunoassay that detects HIV-1 and HIV-2 antibodies and the HIV-1 p24 antigen, with supplemental testing after a reactive assay result to differentiate between HIV-1 and HIV-2 antibodies. (medscape.com)
  • This alterations can lead to the misinterpretation of the diagnostic outcomes by the laboratory further causing inappropriate selection of course of treatment being given by the healthcare professionals. (alliedmarketresearch.com)
  • Global task trainers market is majorly driven by the growing need to curtail healthcare costs which is primarily attributed to the shortage of healthcare professional, increased healthcare spending, increased administrative expenses, changing lifestyle, and growing incidence of chronic disorders and population in general. (meticulousresearch.com)
  • In addition, growing emphasis on patient safety and outcomes further drives the global task trainer market since it addresses a long standing concern of medical errors in healthcare practices. (meticulousresearch.com)
  • India, the Middle East and Africa are emerging markets where players in the blood screening industry can benefit from rising disposable incomes and improved healthcare infrastructures. (marketsandmarkets.com)
  • Around 10% of the world's GDP is constituted of global healthcare spending, which has been steadily rising in recent years as a result of the population's rising healthcare needs. (persistencemarketresearch.com)
  • Over 60% of clinical decisions are influenced by In-Vitro Diagnostics, which is important to the healthcare sector. (persistencemarketresearch.com)
  • Blood collection is a fundamental aspect of medical diagnostics, widely used by healthcare professionals to manage and treat various illnesses. (cognizancemarketresearch.com)
  • As a result, the market for these devices is expected to grow significantly, reflecting their potential to revolutionize healthcare by addressing the rising need for blood collection worldwide. (cognizancemarketresearch.com)
  • In vitro diagnostic testing costs little to the healthcare system and contributes much to clinical practice, which is part of the reason there is so much interest in the industry. (bioinfoinc.com)
  • The growing adoption of home-based healthcare and telemedicine, along with the increasing focus on preventive healthcare, are providing growth opportunities for the market. (marketresearchcommunity.com)
  • Furthermore, the limited availability of POC diagnostic tests in developing countries, combined with insufficient infrastructure and resources, as well as low healthcare spending in these regions, are also impeding market growth. (marketresearchcommunity.com)
  • Adoption of home-based healthcare and telemedicine, focus on preventive healthcare, investment in R&D, and launch of innovative POC diagnostic devices are contributing to market growth. (marketresearchcommunity.com)
  • Significant growth opportunities exist in untapped markets in developing countries with increasing healthcare spending. (marketresearchcommunity.com)
  • Increased demand for rapid diagnostic tests and shift to home-based healthcare boosted demand for POC diagnostic devices. (marketresearchcommunity.com)
  • Decreased healthcare spending due to economic impact also impacted market growth. (marketresearchcommunity.com)
  • At Mindray, our commitment, along with the seamless and genuine efforts, will surely help us to expand our growth in India at an incredible rate as a brand, and we will soon be able to become a top-notch partner for transforming the healthcare landscape in India, and help the healthcare givers as their trusted partner for building a healthier Bharat. (medicalbuyer.co.in)
  • This segment is expected to grow two-fold by the end of 2031 due to increasing usage of immunoassay interference blockers in research activities to introduce novel applications. (medgadget.com)
  • There is an increasing demand for reagents and consumables segment due to the rising demand for high-throughput screening with the help of immunoassays which has resulted in the production of new reagents to detect antigens. (countyenews.com)
  • Furthermore, there is a rise in the implementation of fluorescence and chemiluminescence technology with new reagents which has fuelled the growth of this segment. (countyenews.com)
  • This is boosting segment growth. (marketresearchfuture.com)
  • Luminex's current infectious disease portfolio will benefit from Nanosphere's Verigene technology, which is said to lead in the high-growth bloodstream infection segment. (medicaldevice-network.com)
  • Several factors are driving the growth of this segment, including the growing prevalence of musculoskeletal disorders, the high incidence of bone injuries, and the growing adoption of technologies such as 3D printing for orthopedic implant manufacturing. (meticulousresearch.com)
  • Based on product type, the instruments segment is anticipated to record the highest growth in the clinical diagnostics market due to increasing initiatives by public and private players in expanding laboratory infrastructure and the introduction of innovative testing kits for rapid diagnosis of diseases like HIV, and diabetes, etc. (labmedica.com)
  • Membranes segment accounted for the largest share in the lateral flow assay components market. (westafricana.com)
  • Additionally, the increasing utilization of sequencing in specific areas of interest such as reproductive health, oncology, agriculture, and animal research, and the capability of sequencing kits to enhance throughput, efficiency, and run-time across a wide range of applications contribute to the significant market share of this segment. (meticulousresearch.com)
  • The large market share of this segment is attributed to the technology's high accuracy in DNA sequencing, its capability to generate high-yield error-free throughput, and the growing integration of this technology in clinical and research settings. (meticulousresearch.com)
  • The growth in self-monitoring of blood glucose, which is by far the largest segment of POC testing, is in part a testament to this need for more convenient and effective care. (jaipurherald.in)
  • Reagents & kits segment accounted for the largest share in the In-Vitro Diagnostics/IVD Market. (jaipurherald.in)
  • The reagents & kits segment accounted for the largest share of 68.1% of the market in 2020. (jaipurherald.in)
  • Accessibility to a wide range of reagents and the need for reliable, specific, and faster detection of chronic diseases and genetic disorders in the early stages are expected to drive the growth of this segment. (jaipurherald.in)
  • The large share of this segment can be attributed to the rising prevalence of infectious diseases and multi-drug-resistant infectious diseases and the growing need for effective diagnostic tools for these diseases. (jaipurherald.in)
  • Factors contributing to the large share of this segment include the growing adoption of diagnostic products based on immunodiagnostic technology and the development of advanced diagnostic immunoassay tests. (chatsdumonde.net)
  • Factors driving the growth of this segment include the increasing canine population as pets and the growing prevalence of diseases such as diabetes. (chatsdumonde.net)
  • The Glucose Monitoring Products segment is expected to hold a significant share of the market due to the increasing prevalence of diabetes. (marketresearchcommunity.com)
  • The Syphilis Immunoassay Diagnostics Market report focuses on overall industry dynamics, potential markets, constraints, current market trends, and market limitations to help users find business opportunities and market strategies to expand globally. (startribunemag.com)
  • The report also explores regions such as Europe and Asia-Pacific.Regional dynamics are covered in reports that include the market driver major restraining factors, regional trends, etc. (startribunemag.com)
  • This report offers an up-to-date analysis of the current market scenario, the latest trends and drivers, and the overall market environment. (countyenews.com)
  • this report also lessons the global Sepsis Diagnostics market status, competitive landscape and analysis, market size and share, future trends, market key drivers, opportunities analysis, and key challenges. (openpr.com)
  • Organized references of major market trends. (openpr.com)
  • Asia Pacific (APAC) region was experiencing significant growth and presented several trends and factors contributing to this expansion. (giiresearch.com)
  • The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. (marketsandmarkets.com)
  • ü The study provides an in-depth analysis of the global multiplex assay market along with the current trends and future estimations to elucidate the imminent investment pockets. (articlepedia.xyz)
  • ü An extensive analysis of the key segments of the industry helps to understand the global trends in the multiplex assay market. (articlepedia.xyz)
  • Additionally, developing portable sequencing technologies and increasing partnerships & collaborations among NGS product manufacturers to expand and improve product offerings are prominent trends in the sequencing kits market. (meticulousresearch.com)
  • World Market for Cancer Diagnostics identifies several significant trends occurring in the cancer IVD market currently, spanning a range of aspects and subjects from technology trends to regulatory trends. (kaloramainformation.com)
  • The report on the global gene amplification technologies market includes an assessment of the market, trends, segments, and regional markets. (growthmarketreports.com)
  • The Cosmetic Surgery Market Report provides a comprehensive analysis of the global Cosmetic Surgery market, highlighting key trends, growth drivers, challenges, and opportunities. (articledistrict.com)
  • We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. (articledistrict.com)
  • In terms of product , the global life science reagents market has been classified into chromatography reagents, molecular diagnostic reagents, immunoassay reagents, clinical chemistry reagents, flow cytometry reagents, cell & tissue culture reagents, hematology & hemostasis reagents, microbiology reagents, and others. (dailybn.com)
  • According to the UN Population Division, the global aging population is set to increase from 880 million in 2011 to 2 billion by 2050, representing 22% of the world's population. (meticulousresearch.com)
  • It is a $69.2 billion-dollar market, with lots of players. (bioinfoinc.com)
  • April 2019, Gold Standard Diagnostics, a supplier of complete diagnostics solution announces the debut of patented technology that performs a serological test for syphilis and holds a US patent. (startribunemag.com)
  • OBJECTIVE: We adapted the Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) tool for studies of cervical cancer screening and management and used the adapted tool to evaluate the quality of studies included in a systematic review supporting the 2019 Risk-Based Management Consensus Guidelines. (cdc.gov)
  • Increase in aging population is likely to escalate demand for diagnostic kits and reagents for the detection of age-related as well as other chronic conditions. (medgadget.com)
  • Immunoassay interference blocker kits and reagents play a vital role in preventing unnecessary interference generated while preforming an immunoassay-based disease detection test. (medgadget.com)
  • The Immunoassay Interference Blocker Market is expected to grow on a healthy note in the subsequent decade. (medgadget.com)
  • Heavy investments in research and development activities related to immunoassay interference inhibitors with the motive of gaining accuracy in clinical diagnosis, to reduce the degree of errors for the results of biochemical analysis and advancement in blocker used for interference and kits manufacturing are the major drivers for growing immunoassay interference blocker market. (alliedmarketresearch.com)
  • Among the noteworthy drivers of the infectious disease diagnostics market, the rising prevalence of infectious diseases turns out to be the major factor for accelerating the infectious disease diagnostics market. (globenewswire.com)
  • Further, rising incidences of epidemics and pandemics across the world is going to boost the market growth for infectious disease diagnostics. (globenewswire.com)
  • The rising burden of infectious diseases across the globe has increased the demand for infectious disease diagnostics products. (persistencemarketresearch.com)
  • Immunoassays are more readily available, accessible, easy to use, and have rapid turnaround time when compared to other methods of disease diagnosis. (globenewswire.com)
  • Also, the immunoassays are less costly than high tech instruments which are currently utilized for infectious disease diagnosis. (globenewswire.com)
  • Although immunoassays are used as confirmatory tests along with other tests for infectious disease diagnosis but in certain diseases such as Lyme disease, syphilis, and others, they are primary means for disease detection. (globenewswire.com)
  • Furthermore, constant clinical efforts and research studies emphasized on improvising diagnosis of various diseases and disorders in order to provide efficient treatment and care to patients, advancement in the new drug discoveries and diagnostics biologics further catalyzes the growth of this market. (alliedmarketresearch.com)
  • Major growth drivers for global adrenocorticotropic hormone market include increasing incidence of adrenal insufficiency and autoimmune diseases, growing awareness about the benefits of early diagnosis and treatment, and the availability of advanced diagnostic techniques. (blueweaveconsulting.com)
  • These techniques help in the early diagnosis of adrenal insufficiency, which is a major factor driving the growth of the ACTH market. (blueweaveconsulting.com)
  • However, the high costs of sequencing kits & reagents and the ethical & legal issues related to DNA sequencing-based diagnosis are factors restraining the growth of this market. (meticulousresearch.com)
  • The growth of the In-Vitro Diagnostics/IVD Market is mainly driven by the rising geriatric population and the subsequent growth in the prevalence of chronic and infectious diseases, increasing adoption of fully automated and POC instruments in developed regions, growing awareness regarding diseases diagnosis in developing regions, and growing R&D investments by industry players to launch new IVD products. (jaipurherald.in)
  • Additionally, the diagnosis of infectious and chronic diseases is one of the leading applications of in-vitro diagnostics. (dailybn.com)
  • The rising prevalence of chronic kidney disorders among people in the United States is a major factor attributed to the increasing usage of renal biomarkers for effective diagnosis and to boost the market growth in this region. (futuremarketinsights.com)
  • Additionally, the increasingly vulnerable aging population that is prone to chronic kidney diseases in the United States is also contributing to the rising demand for early-stage diagnosis and effective treatment, thereby contributing to the growth of the market. (futuremarketinsights.com)
  • Increasing prevalence of infectious diseases and emergence of COVID-19 are some key factors driving market revenue growth. (gpworldtech.com)
  • Prevalence of infectious diseases has been rising, in both developed and developing countries, and resulting in steady demand for infectious disease rapid diagnostic testing. (gpworldtech.com)
  • The high prevalence of infectious diseases worldwide, rapid growth in the geriatric population, the growing demand for point-of-care testing, the increased demand for lateral flow assay components due to COVID-19, and the rising use of home-based lateral flow assay devices are the major factors driving the growth of the lateral flow assay components market. (westafricana.com)
  • The report chiefly studies the Sepsis Diagnostics market dynamics, industry recent development, and progression status, as well as investment chances, growth rate, and latest emerging technology, industry expansion policies and advancement will further enhance the performance of the product, creating it more extensively used in downstream applications. (openpr.com)
  • Interference may cause an impact over a wide range of analytes measured by immunoassay including hormones, tumor markers, drugs, cardiac troponin and microbial serology. (alliedmarketresearch.com)
  • The immunoassay instruments help in detecting the concentration and presence of analytes in the blood, plasma and urine samples. (postingtree.com)
  • In addition, the take a look at gives a whole assessment of those factors, alongside relevant market segments and sub-segments. (openpr.com)
  • Analysis of the segments and their growth projection is carried out by extensive historical and current analysis of the market scenario. (gpworldtech.com)
  • Specialty immunoassays, continuous glucose tests, mass spectrometry and inherited diseases are other large and high-growth segments. (bioinfoinc.com)
  • In the more mature segments, there is no lack of activity: Major core lab vendors such as Siemens, Roche, OrthoClinical and Abbott Diagnostics are developing improved models selling their existing on staying with them. (bioinfoinc.com)
  • In addition, we are gaining the confidence of our customers and rapidly expanding our installed base in a variety of segments like immunoassay, clinical chemistry, endoscopy, surgical units, and infusion systems by delivering innovative and easy-to-use solutions that enhance clinical decision-making. (medicalbuyer.co.in)
  • Patients suffering from chronic kidney disease and cancer disorders require the urgent intervention of clinical diagnostics. (labmedica.com)
  • The benefits of clinical diagnostics such as quick test results, easy testing procedure, seamless sample procurement, and less pain are driving the demand for diagnostics instruments. (labmedica.com)
  • This is likely to boost the growth of the clinical diagnostics market. (labmedica.com)
  • This is expected to drive the expansion of the clinical diagnostics market over the coming years. (labmedica.com)
  • The increased adoption of Endocrine Testing in the Clinical Diagnostics is due to high workability, Stability of structure, good quality, and Demand for making things better. (marketresearchcommunity.com)
  • Increasing technological advancement such as molecular services and next generation sequencing (NGS) are expected to boost the market growth. (growthmarketreports.com)
  • The rising number of IVD (in vitro diagnostics ) products being launched by key players is also fueling the growth of the market. (grandviewresearch.com)
  • All image credit: Colder Product Company The in vitro diagnostics (IVD) market continues to grow at an almost breakneck pace, along with laboratory demands for increasingly complex and efficient equipment. (cytofluidix.com)
  • This has significant potential to boost Infectious Disease in In-Vitro Diagnostics. (persistencemarketresearch.com)
  • The United States will continue to be the largest shareholder of the Infectious Disease In-Vitro Diagnostics Market throughout the analysis period accounting for over US$ 9.4 Bn absolute dollar opportunity in the coming 10-year period. (persistencemarketresearch.com)
  • How are key drivers going to affect the Infectious Disease In-Vitro Diagnostics Market? (persistencemarketresearch.com)
  • This suggests that there is a huge opportunity for in-vitro diagnostics that are affordable. (persistencemarketresearch.com)
  • Government support is a key driver of growth for the In-Vitro Diagnostics market in the near future because increased funding from the government enables research institutions to create quick analysis systems that are helpful for diagnosing a variety of diseases using various samples. (persistencemarketresearch.com)
  • In-Vitro Diagnostics technologies were only applied in clinical labs in the past. (persistencemarketresearch.com)
  • Based on product and service, the In-Vitro Diagnostics Market is segmented into reagents & kits, instruments, services, and data management software. (jaipurherald.in)
  • The outbreak of infectious viruses such as Zika, in 2015, positively impacted the in-vitro diagnostic industry. (dailybn.com)
  • Kalorama's report, The Worldwide Market for In Vitro Diagnostics Tests is a comprehensive global report designed to track those activities. (bioinfoinc.com)
  • Global demand for circulating tumor cell (CTC) testing products is projected to rise 6% annually through 2026. (kaloramainformation.com)
  • The rise in the geriatric population and growth in knowledge regarding early testing has led to a surge in the number of regular check-ups, as a majority of deaths due to infections and chronic conditions occur in the population aged over 75 years. (grandviewresearch.com)
  • The rising geriatric population worldwide is expected to have a positive impact on the global adrenocorticotropic hormone (ACTH) market. (blueweaveconsulting.com)
  • The growth of the global life science reagents market is attributed to the increase in the global geriatric population, which is more prone to different types of infectious diseases. (dailybn.com)
  • The market is driven by factors such as the increasing prevalence of autoimmune and inflammatory diseases, growing demand for advanced diagnostic techniques, and increasing adoption of biologics. (blueweaveconsulting.com)
  • What are the Market Factors that are Clarified in the Report? (openpr.com)
  • Therefore, the growth of this market will boost in this region because of the aforementioned factors. (giiresearch.com)
  • All of the aforementioned factors contribute to an increase in the number of tests, resulting in market growth. (marketresearchfuture.com)
  • The industry is witnessing growth due to factors, such increasing burden of chronic diseases and the growing demand for early diagnostic tests. (grandviewresearch.com)
  • Further, the report offers details about the factors and features of the Infectious Disease Rapid Diagnostic Testing market expected to boost the growth of the industry in the coming years. (gpworldtech.com)
  • Other key factors that drives task trainer market includes consistent development in medical simulation technologies, shortage of real life patients for practice purpose, and growing preference to minimal invasive surgeries. (meticulousresearch.com)
  • However, there are certain factors that have restraining effect on this market such as fidelity of task trainer, which is nothing but the inability of task trainers to imitate the emotional attributes of the patients. (meticulousresearch.com)
  • However, high capital investment and dearth of skilled labors are the major factors that hinder the market growth. (articlepedia.xyz)
  • ü A comprehensive analysis of the factors that drive and restrict the market growth is provided. (articlepedia.xyz)
  • Other factors driving the market include a growing need for early detection of chronic diseases, higher rates of accidents and injuries, and a global rise in surgeries. (cognizancemarketresearch.com)
  • The major factors attributing to the market's growth include rising blood donations, an increase in the incidence of infectious diseases, and government initiatives, all contributing to the market's rapid growth. (mordorintelligence.com)
  • Factors such as the high incidence of a drugs overdose and the adoption of acetaminophen testing drive the market growth. (theinsightpartners.com)
  • The factors such as limited availability of raw materials, transportation restrictions, the shutdown of manufacturing facilities, and economic slowdown are the major impacts of COVID-19 which hampered the market growth. (marketresearchcommunity.com)
  • The factors such as the large and easy availability of basic things, rising purchasing power among the population, and favorable government policies and industrial facilities are estimated to accelerate the industry growth in the region. (marketresearchcommunity.com)
  • Furthermore, increasing investments in research and development is one of the major factors that is anticipated to boost the market growth, as renal biomarkers are widely used in preclinical and clinical trials, to assess the safety of new drugs. (futuremarketinsights.com)
  • Rising government funding & grants towards genomics and growing customized medicine are key factors propelling the market growth. (growthmarketreports.com)
  • Inadequacy of skilled personnel for handling the testing devices and high cost of instruments are major restraining factors expected to hamper the market growth. (growthmarketreports.com)
  • Governments around the world are supporting the growth of specialty medical diagnostic reagents, which further drives research & development. (medgadget.com)
  • Based in Nashville, US, Symmetry develops and markets reusable, reposable and single-use surgical instrumentation and specialty devices catering to the comprehensive need of clinicians and improved patient care. (medicaldevice-network.com)
  • US-based medical device company Luminex signed a definitive agreement to acquire Nanosphere, a molecular microbiology and molecular diagnostic company, for approximately $58m. (medicaldevice-network.com)
  • Following the acquisition, Luminex's existing customer base will be boosted by Nanosphere's Verigene platform, range of services and experience in the molecular microbiology market with more than 240 customers. (medicaldevice-network.com)
  • The MALDI-TOF market has exploded in recent years in microbiology labs thanks largely to the IVD regulatory approval of the VITEK MS and MALDI Biotyper. (bioinfoinc.com)
  • T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced the presentation of data on endotoxin detection at the American Society for Microbiology General Meeting, June 16-19, 2012, in San Francisco, CA. (news-medical.net)
  • Substances present in the body such as polyreactive antibodies or heterophiles, or human anti-animal antibodies coupled with some other binding proteins can cause interference due to reactions between analyte and reagent antibodies in immunoassay. (alliedmarketresearch.com)
  • Associates of Cape Cod, Inc., (ACC) is proud to introduce its NEW CHROMOGENIC ENDOTOXIN DETECTION SYSTEM incorporating the enhanced Pyrochrome® chromogenic reagent and the new-to-market Pyros Kinetix® Flex Incubating Kinetic tube reader. (news-medical.net)
  • One of the diagnostic test for HIV is Nucleic Acid Test (NAT), where the blood is usually drawn from the vein and tested for the presence of virus. (globenewswire.com)
  • Additionally, the rising number of emergency use authorizations for diagnostic kits & devices, and developments & support by non-medical device/diagnostic companies also boost the market. (marketresearchfuture.com)
  • Additionally, the increasing global waste generation has created a pressing need for waste management solutions capable of converting waste into valuable products. (openpr.com)
  • request Analysis, pricing analysis, competitive landscape, and benchmarking of key market players.This report will help industry investors, market players and stakeholders to make critical plans and develop jobs Strategies to maintain market presence in the global market. (startribunemag.com)
  • The research includes comprehensive profiles of the key players in the market and an analysis of the competitive landscape. (marketresearchcommunity.com)
  • The report has also analysed the competitive landscape of the market with some of the key players being. (postingtree.com)
  • ü A comprehensive quantitative analysis of the industry is provided from 2018 to 2025 to assist stakeholders to capitalize on the prevailing market opportunities. (articlepedia.xyz)
  • Siemens Healthineers announced today the CE Mark and global commercial availability of its Atellica™ Solution-flexible, scalable, automation-ready immunoassay and chemistry analyzers. (cytofluidix.com)
  • ACTH is a biologic hormone that is used to treat these conditions, and the increasing adoption of biologics is expected to boost the growth of the ACTH market. (blueweaveconsulting.com)
  • The diagnostic techniques such as Quantitative or Real-time reverse transcription polymerase chain reaction (qRT-PCR or rRT-PCR), immunoassays, and others were employed in the detection of SARS-CoV-2 virus which is the causative agent for COVID- 19. (globenewswire.com)
  • A team of international, multi-institutional researchers led by Wyss Institute for Biologically Inspired Engineering at Harvard University synthetic biologist James Collins has developed a rapid paper-based diagnostic system for strain-specific detection of the Zika virus. (medicaldevice-network.com)
  • A big boost in research support also came from the military, especially from DARPA (Defense Advanced Research Projects Agency), for their interest in portable biological, and chemical warfare agent detection systems. (wikipedia.org)
  • Early detection and linking of therapy to patient should drive cancer diagnostics. (bioinfoinc.com)
  • Immediate detection of COVID-19 cases necessitated a wide range of diagnostics to control the virus's rapid spread. (mordorintelligence.com)
  • This can be ascribed to the superior diagnostic features associated with the immunoassays over other diagnostic tests. (globenewswire.com)
  • The market refers to the industry focused on developing, producing, and distributing diagnostic tests, instruments, and services used to diagnose and monitor diseases in animals, primarily pets and livestock. (giiresearch.com)
  • Reagents and consumables are essential supplies used in diagnostic tests. (giiresearch.com)
  • The integration of biomarkers and the availability of biomolecular tools are expected to help develop a new range of condition-specific tests, thus creating new opportunities for the IVD market. (jaipurherald.in)
  • Also, the development of disease-specific markers and tests is expected to offer potential growth opportunities to market players in the coming years. (jaipurherald.in)
  • Animal diagnostic tests help detect various animal diseases. (chatsdumonde.net)
  • Some of the major restraints include the high cost of POC diagnostic devices, the lack of standardization and regulatory approval for many POC diagnostic tests, limited reimbursement for POC diagnostic tests, a lack of awareness about these tests, and a shortage of trained personnel to operate POC diagnostic devices. (marketresearchcommunity.com)
  • This proliferating cancer threat is boosting world demand and growth opportunities for specific, sensitive tests, as well as precision medicine and companion diagnostics for treating cancer. (kaloramainformation.com)
  • The urgent need to improve the outcome of patients with various forms of cancer is boosting opportunities for new and existing tests that help detect tumors early, determine disease risk, identify and assess the effectiveness of therapies, and assist in the discovery and commercialization of new improved anti-cancer agents. (kaloramainformation.com)
  • For the next several years, the liquid biopsy market is expected to be driven primarily by tests that detect mutations significant to targeted therapy selection. (kaloramainformation.com)
  • Therefore, such clinical trials will boost the development of biomarker tests in the country. (futuremarketinsights.com)
  • The increasing adoption of rapid tests and point-of-care (PoC) testing for drug monitoring and alcohol abuse is acting as another major growth-inducing factor. (postingtree.com)
  • The near-patient treatment of strokes, infectious diseases, and cancer are now possible as the key players in the clinical diagnostic market are making huge investments in enhancing the specificity and sensitivity of testing devices using smaller specimen samples. (labmedica.com)
  • Strengthening health promotion measures, increasing use of improved technology, and increasing consumer awareness are further drivers driving growth in the region. (startribunemag.com)
  • Capgemini Invent is an integral part of Capgemini, a global leader in partnering with companies to transform and manage their business by harnessing the power of technology. (cambridgeconsultants.com)
  • However, the regulatory framework for approvals has always posed major restraints on the growth rate of the pharmaceutical, biotechnology, and medical technology industries. (grandviewresearch.com)
  • Our report has categorized the market based on region, technology, product, application and end use. (postingtree.com)
  • These restraints are limiting the growth of the point-of-care diagnostic market and need to be addressed in order to achieve further growth in the market. (marketresearchcommunity.com)
  • A Global Infectious Disease Rapid Diagnostic Testing Market Research Report from Emergen Research has been formulated by analyzing key business details and an extensive geographic spread of the Infectious Disease Rapid Diagnostic Testing industry, encompassing key business details and extensive geographical coverage. (gpworldtech.com)
  • In addition to providing crucial statistical data about the Infectious Disease Rapid Diagnostic Testing market, this study covers qualitative and quantitative aspects of the Infectious Disease Rapid Diagnostic Testing market. (gpworldtech.com)
  • Immunoassay interference blocker kit consists of reagents that are specifically designed to that neutralize or inhibit the interference and prevent faulty results that enhances the overall assay performance as well. (alliedmarketresearch.com)
  • For thorough analysis of market players, the global Syphilis Immunoassay Diagnostics Market research report is segmented on the basis of product type. (startribunemag.com)
  • This research report categorizes the Sepsis Diagnostics market by top vendors, region, type, and end-user. (openpr.com)
  • The market research report covers the analysis of key stake holders of the market. (giiresearch.com)
  • This non-animal alternatives testing market research report provides a comprehensive view of everything you require, including an in-depth analysis of the industry's current and future scenario. (thebusinessresearchcompany.com)
  • Endocrine Testing Market Research Report" was just released by Market Research Community. (marketresearchcommunity.com)
  • New syphilis analysis techniques are becoming more popular in the syphilis immunoassay diagnostic market. (startribunemag.com)
  • To help businesses improve their market position, Technavio's report provides a detailed analysis of around 15+ vendors operating in the market. (countyenews.com)
  • Software plays an increasingly important role in veterinary diagnostics, helping with data analysis, reporting, and the management of diagnostic information. (giiresearch.com)
  • A comprehensive analysis of established and emerging players in the market is summarized in the report. (gpworldtech.com)
  • The new research study consists of an industry trend analysis of the market. (marketsandmarkets.com)
  • Although the application of LOCs is still novel and modest, a growing interest of companies and applied research groups is observed in different fields such as chemical analysis, environmental monitoring, medical diagnostics and cellomics, but also in synthetic chemistry such as rapid screening and microreactors for pharmaceutics. (wikipedia.org)
  • It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. (openpr.com)
  • Advances in liquid biopsy technologies will foster growth by expanding the number of tumor cells that can be readily extracted for analysis. (kaloramainformation.com)
  • The growth in precision medicine is projected to enhance the overall demand for such novel reagents and consumables. (grandviewresearch.com)
  • This is expected to boost the demand for ACTH therapy, which is used to manage symptoms associated with chronic conditions such as multiple sclerosis and rheumatoid arthritis. (blueweaveconsulting.com)
  • It is expected that such initiatives by different organizations will raise awareness of the disease and increase the demand for its diagnostic solutions. (openpr.com)
  • Due to these increasing numbers of cases, there is a growing demand for more COVID-19 testing kits and devices, hence driving the market's growth. (marketresearchfuture.com)
  • Large-scale population-based testing is necessary to strengthen COVID-19 preventive and control efforts and measures, which is expected to continue to drive increased demand for infectious disease diagnostic products in future. (gpworldtech.com)
  • The slowdown in economic growth and dynamic changes in demand will further affect industry growth. (gpworldtech.com)
  • Due to these advantages, the global demand for self-sampling blood collection and storage devices has been steadily increasing. (cognizancemarketresearch.com)
  • The global point-of-care diagnostic market is expected to grow due to the increasing demand for rapid, convenient, and cost-effective medical testing. (marketresearchcommunity.com)
  • The growing demand for rapid, convenient, and cost-effective medical testing is the primary driver of the point-of-care diagnostic market. (marketresearchcommunity.com)
  • The global market for organic waste treatment system fuel is experiencing significant growth owing to the rising demand for sustainable and renewable energy sources. (openpr.com)
  • As a result, rising awareness and a high demand for safe blood transfusion are creating opportunities for market growth in emerging countries. (mordorintelligence.com)
  • Post covid-19, there was a positive impact on the market growth due to the increased industrial manufacturing processes and rising demand for environment-friendly alternatives. (marketresearchcommunity.com)
  • The growth of the market is attributed to the rising demand for genetic information for the purpose of identifying & planning all the genes of the human genome. (growthmarketreports.com)
  • Increased efficacy in operations, technical expertise, and on demand service for analytical testing devices are fueling the market expansion. (growthmarketreports.com)
  • The increasing prevalence of chronic diseases, the growing aging population, and the focus on patient-centered care are also driving the growth of the market. (marketresearchcommunity.com)
  • However, the evolving regulatory landscape, the low chances of positive, actionable mutations, and the lack of sequencing professionals in developing countries are major challenges for market growth. (meticulousresearch.com)